focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 327.50
Bid: 326.00
Ask: 328.00
Change: 23.00 (7.55%)
Spread: 2.00 (0.613%)
Open: 307.00
High: 331.00
Low: 300.00
Prev. Close: 327.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Apr 2015 08:15

RNS Number : 1252J
Synthomer PLC
01 April 2015
 

01 April 2015 

Synthomer plc

Appointment of Chief Financial Officer

Synthomer plc ('Synthomer' or 'the Company') announces that it has appointed Steve Bennett as its Chief Financial Officer. Steve will join Synthomer in July and will succeed David Blackwood, who announced in December that he would step down from the role after seven years. David will leave the Company after a brief handover period.

Steve joins from INEOS Group ('INEOS') where he has been Chief Financial Officer at Petroineos Refining Limited, a JV between INEOS Group AG and PetroChina, since 2006. In addition to this role, he has acted as Chief Financial Officer of INEOS Upstream Limited, a start-up oil and gas exploration business, and of INEOS Olefins and Polymers South and INEOS Phenol.

Steve joined Coopers & Lybrand in 1986 and is a qualified Chartered Accountant. He joined Full Circle Industries plc as Company Secretary and Group Controller before moving to PricewaterhouseCoopers ('PWC') in 1997 as a Director in Transaction Services. At PWC, he specialised in public and private equity transactions across a variety of sectors including chemicals.

Neil Johnson, Chairman, said:

"I am delighted to welcome Steve to Synthomer. He has a superb track record at INEOS and thirty years of experience working in finance across a broad range of sectors, not least the chemical industry. I have no doubt that Steve's considerable knowledge and skills will be invaluable to the Group as we move forward.

On behalf of the Board, I would once again like to thank David for his seven years of service. His contribution has been instrumental in helping Synthomer through a significant transformation and we wish him all the best for the future."

Calum MacLean, Chief Executive, said:

"I have known Steve for the past ten years and I am delighted to welcome someone of his calibre to Synthomer. His significant experience will be of enormous benefit to me and the senior team as we look to take Synthomer into a new phase of its growth."

There are no further details required to be disclosed under LR 9.6.13R of the Listing Rules of the UK Listing Authority.

-ENDS-

Enquiries:

Synthomer plcNeil Johnson, ChairmanCalum MacLean, Group Chief Executive

 

+ 44 (0) 1279 436 211

Pendomer Charles Armitstead

+44 (0) 20 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUAABRVSASRRR
Date   Source Headline
11th May 20205:21 pmRNSHolding(s) in Company
11th May 20209:03 amRNSDirector/PDMR Shareholding
11th May 20209:02 amRNSDirector/PDMR Shareholding
11th May 20208:59 amRNSDirector/PDMR Shareholding
11th May 20208:58 amRNSDirector/PDMR Shareholding
29th Apr 20203:17 pmRNSResult of AGM
29th Apr 20207:00 amRNSQ1 Trading and COVID-19 Update
1st Apr 20202:44 pmRNSCompletion of OMNOVA acquisition
1st Apr 20207:00 amRNSAnnual Financial Report
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
30th Mar 20207:00 amRNSAppointment of Deputy Chair and Chair-elect
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
26th Mar 202010:17 amRNSEuropean Commission clearance for OMNOVA
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20209:50 amRNSDirector/PDMR Shareholding
13th Mar 20205:29 pmRNSDirector/PDMR Shareholding
9th Mar 20202:45 pmRNSHolding(s) in Company
5th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
31st Jan 20209:36 amRNSDirector Declaration
15th Jan 20202:21 pmRNSAcquisition of OMNOVA receives EC clearance
6th Dec 20197:00 amRNSAppointment of Broker
13th Nov 20192:53 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSDirector Declaration
25th Oct 20197:00 amRNSQ3 Trading Update
22nd Oct 20197:00 amRNSAGM Statement
11th Oct 20197:00 amRNSOmnova shareholders approval
14th Aug 20193:25 pmRNSHolding(s) in Company
13th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSInterim Results for 6 months ended 30 June 2019
2nd Aug 201910:29 amRNSHolding(s) in Company
1st Aug 20199:05 amRNSHolding(s) in Company
31st Jul 201910:51 amRNSResults of Extraordinary General Meeting
30th Jul 20191:07 pmRNSDirector/PDMR Shareholding
30th Jul 20191:03 pmRNSDirector/PDMR Shareholding
30th Jul 20191:02 pmRNSDirector/PDMR Shareholding
30th Jul 20191:01 pmRNSDirector/PDMR Shareholding
30th Jul 201912:59 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:55 pmRNSDirector/PDMR Shareholding
30th Jul 201912:54 pmRNSDirector/PDMR Shareholding
30th Jul 201912:53 pmRNSDirector/PDMR Shareholding
30th Jul 201912:52 pmRNSDirector/PDMR Shareholding
30th Jul 201912:51 pmRNSDirector/PDMR Shareholding
30th Jul 201912:50 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201911:31 amRNSResults of Rump Placing
30th Jul 20197:00 amRNSResults of Rights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.